Clinical Trial Update: A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of zoledronic acid, pravastatin, and lonafarnib for Progeria (Hutchinson-Gilford syndrome) completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progeria

Drugs mentioned

• Lonafarnib (lonafarnib)
• Pravastatin (pravastatin)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Progeria, Hutchinson-Gilford Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-07-31